Organisation paid for research Program year 2025 Source: CMS Open Payments

Burke Primary Care LLC

Neither a doctor nor a teaching hospital

Research payments

$370,048

36 payments

Through program year 2025, Burke Primary Care LLC is reported as receiving $370,048 in research payments, across 36 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$63,359	1
2024	Research	$10,000	1
2022	Research	$4,068	4
2020	Research	$74,972	2
2019	Research	$217,650	28

Breakdown

Who paid Research payments · program years 2019–2025

Novo Nordisk AS $215,808 25 payments
Lexicon Pharmaceuticals, Inc. $74,114 1 payment
Amgen Inc. $63,359 1 payment
Janssen Research & Development, LLC $10,000 1 payment
Ardelyx, Inc. $4,068 4 payments
Pfizer Inc. $2,700 4 payments

Studies the money was for Research payments · program years 2019–2025

Ex9536-4388 $177,961 12 payments
Efc-14875 $74,114 1 payment
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity $63,359 1 payment
Nn2211-4232 $31,057 7 payments
A Phase 2b Randomized Double blind Placebo controlled Study to Evaluate the Efficacy and Safety of Rilematovir JNJ53718678 in Adult Outpatients with Respiratory Syncytial Virus RSV Infection who are at High Risk for RSV related Disease Progression $10,000 1 payment
Nn9535-4321 $6,790 6 payments
Study to Evaluate the Use of Tenapanor As Core Therapy in the Treatment of Hyperphosphatemia (Optimize) $4,068 4 payments
A Phase 3 Randomized Doubleblind Placebocontrolled 26Week Multicenter Study With A 78Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Mo $2,700 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.